Real-World Adherence and Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists Therapy in Type 2 Diabetes Mellitus Patients in the United States

AIM: To assess adherence and discontinuation of injectable glucagon-like peptide-1 receptor agonists (GLP-1 RA) at 12 and 24 months among adult type 2 diabetes mellitus (T2DM) patients in the United States initiating GLP-1 RA using the administrative claims-based database, Optum Clinformatics(®) Dat...

Descripción completa

Detalles Bibliográficos
Autores principales: Weiss, Tracey, Carr, Richard D, Pal, Sampriti, Yang, Lingfeng, Sawhney, Baanie, Boggs, Robert, Rajpathak, Swapnil, Iglay, Kristy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7708309/
https://www.ncbi.nlm.nih.gov/pubmed/33273810
http://dx.doi.org/10.2147/PPA.S277676

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7708309/
https://www.ncbi.nlm.nih.gov/pubmed/33273810
http://dx.doi.org/10.2147/PPA.S277676

Ejemplares similares